NRIX Exercise Disclosure
Van Houte Hans · SEC Form 4 · Filed Nov 2, 2026
Exercise
Calculated transaction value
$0
Van Houte Hans Chief Financial Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Oct 30, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 3 days later
NRIX daily price context
Close on/before transaction
$26.8
Oct 30, 2026
First close after public filing
$25.82
Nov 3, 2026
Return after filing · so far
-40.74%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,750 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001817217-26-000014
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$74.47K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Sale | Oct 30, 2026 | $74.47K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX Current | Exercise | Oct 30, 2026 | $0 |